Zdrowie i gospodarka · 07/04/2015

FDA Releases Guidance on Risk Evaluation and Mitigation Strategies Modifications and Revisions

The Food and Drug Administration (FDA) has published a guidance document outlining the procedures and requirements for submitting modifications and revisions to risk evaluation and mitigation strategies (REMS) to the agency, aiming to clarify the process and ensure compliance with regulatory standards.